The U.S. market value for biomaterials was about $3.4 billion in 2012.
Popular applications for biomaterials — such as polymers, metals, ceramics and natural materials — include bone graft substitute, orthopedic growth factor, orthopedic stem cell, orthopedic cell therapy, spinal machined bone allograft and orthopedic tendon graft.
The report highlights potential hazards involved with biomaterial use, as well as strategies for navigating the market landscape. Several companies will also continue to be key players in the industry, including Invibio Biomaterials, the developer of PEEK products.
More Articles on Orthopedics:
14 Orthopedic Surgeons Treating Professional Athletes
Drs. Michelle E. Horn, Jung H. Park Join Bucks County Orthopedic Specialists
UW Health Names Dr. Warren Dunn Chief of Sports Medicine
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.